NM_013444.4:c.1573C>T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_013444.4(UBQLN2):​c.1573C>T​(p.Pro525Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,194,329 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 49 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P525A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.00012 ( 0 hom. 49 hem. )

Consequence

UBQLN2
NM_013444.4 missense

Scores

4
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:3B:3

Conservation

PhyloP100: -0.0910

Publications

22 publications found
Variant links:
Genes affected
UBQLN2 (HGNC:12509): (ubiquilin 2) This gene encodes an ubiquitin-like protein (ubiquilin) that shares high degree of similarity with related products in yeast, rat and frog. Ubiquilins contain a N-terminal ubiquitin-like domain and a C-terminal ubiquitin-associated domain. They physically associate with both proteasomes and ubiquitin ligases; and thus, are thought to functionally link the ubiquitination machinery to the proteasome to affect in vivo protein degradation. This ubiquilin has also been shown to bind the ATPase domain of the Hsp70-like Stch protein. [provided by RefSeq, Oct 2009]
UBQLN2 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 15
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01776573).
BP6
Variant X-56565446-C-T is Benign according to our data. Variant chrX-56565446-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 29954.
BS2
High AC in GnomAd4 at 20 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBQLN2NM_013444.4 linkc.1573C>T p.Pro525Ser missense_variant Exon 1 of 1 ENST00000338222.7 NP_038472.2 Q9UHD9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBQLN2ENST00000338222.7 linkc.1573C>T p.Pro525Ser missense_variant Exon 1 of 1 6 NM_013444.4 ENSP00000345195.5 Q9UHD9

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
20
AN:
112368
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00642
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.000660
GnomAD2 exomes
AF:
0.000334
AC:
49
AN:
146519
AF XY:
0.000308
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00648
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000818
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000119
AC:
129
AN:
1081961
Hom.:
0
Cov.:
32
AF XY:
0.000139
AC XY:
49
AN XY:
352503
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25977
American (AMR)
AF:
0.00
AC:
0
AN:
32770
Ashkenazi Jewish (ASJ)
AF:
0.00493
AC:
94
AN:
19056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29288
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52374
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39307
Middle Eastern (MID)
AF:
0.00121
AC:
5
AN:
4119
European-Non Finnish (NFE)
AF:
0.0000168
AC:
14
AN:
833609
Other (OTH)
AF:
0.000352
AC:
16
AN:
45461
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000178
AC:
20
AN:
112368
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34514
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30877
American (AMR)
AF:
0.00
AC:
0
AN:
10754
Ashkenazi Jewish (ASJ)
AF:
0.00642
AC:
17
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3539
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2741
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6213
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53155
Other (OTH)
AF:
0.000660
AC:
1
AN:
1516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000912
Hom.:
4
Bravo
AF:
0.000136
ExAC
AF:
0.000260
AC:
31

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 15 Pathogenic:2Uncertain:2Benign:1
Feb 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 21, 2011
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Jan 06, 2020
Reproductive Health Research and Development, BGI Genomics
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

NM_013444.3:c.1573C>T in the UBQLN2 gene has an allele frequency of 0.007 in Ashkenazi Jewish subpopulation in the gnomAD database. The p.Pro525Ser (NM_013444.3:c.1573C>T) variant has been detected in families affected with amyotrophic lateral sclerosis (PMID: 21857683). Functional studies suggest that p.Pro525Ser exhibited intermediate solubility phenotypes compared to wild type (PMID: 29161404). Taken together, we interprete this variant as Pathogenic/Likely pathogenic. ACMG/AMP Criteria applied: PS3; PP4; PM2. -

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Mar 31, 2020
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Uncertain:1
Nov 15, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26944018, 25333069, 26075709, 29161404, 27834214, 28716533, 25398946, 25616961, 26152284, 21857683, 25681989, 34426522, 35047667, 32579787, 30982635, 33891006, 33919255, 31324802, 31942019, 31167121, 32513711, 37039476, 36423739, 35936615, 31319884, 32290710, Durmus2023[Casereport]) -

Amyotrophic lateral sclerosis Benign:1
May 03, 2020
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

UBQLN2-related disorder Benign:1
Apr 03, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
13
DANN
Benign
0.84
DEOGEN2
Benign
0.035
T
FATHMM_MKL
Benign
0.099
N
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.018
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.0
L
PhyloP100
-0.091
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.36
N
REVEL
Uncertain
0.53
Sift
Benign
0.15
T
Sift4G
Benign
0.10
T
Polyphen
0.0010
B
Vest4
0.73
MutPred
0.25
Gain of phosphorylation at P525 (P = 0.012);
MVP
0.97
MPC
0.48
ClinPred
0.010
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.051
gMVP
0.71
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369947678; hg19: chrX-56591879; API